fk 156 has been researched along with Candidiasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukada, S; Goto, S; Kuwahara, S; Mine, Y; Nishida, M; Wakai, Y; Yokota, Y | 1 |
| Goto, S; Kuwahara, S; Mine, Y; Nishida, M; Tawara, S; Watanabe, Y; Yokota, Y | 1 |
2 other study(ies) available for fk 156 and Candidiasis
| Article | Year |
|---|---|
Immunoactive peptides, FK-156 and FK-565. I. Enhancement of host resistance to microbial infection in mice.
Topics: Adjuvants, Immunologic; Amino Acids, Diamino; Animals; Bacterial Infections; Candidiasis; Diaminopimelic Acid; Escherichia coli; Immunity, Innate; Listeria monocytogenes; Male; Mice; Mice, Inbred ICR; Oligopeptides; Structure-Activity Relationship | 1983 |
Immunoactive peptides, FK-156 and FK-565. III. Enhancement of host defense mechanisms against infection.
Topics: Adjuvants, Immunologic; Amino Acids, Diamino; Animals; Bacterial Infections; Candidiasis; Chemotaxis; Cyclophosphamide; Diaminopimelic Acid; Hydrocortisone; Immunity, Innate; Immunosuppression Therapy; Leukocyte Count; Macrophages; Male; Mice; Mice, Inbred ICR; Neutrophils; Oligopeptides; Phagocytosis | 1983 |